PTC Therapeutics Inc (NASDAQ:PTCT)

70.48
Delayed Data
As of Apr 24
 -0.88 / -1.23%
Today’s Change
14.51
Today|||52-Week Range
78.72
+36.14%
Year-to-Date

Today’s Trading

Previous close71.36
Today’s open70.89
Day’s range70.42 - 73.01
Volume337,899
Average volume (3 months)654,787
Market cap$2.4B
Dividend yield--
Data as of 4:00pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+42.66%
Earnings growth (this year)-71.77%
Earnings growth (next 5 years)--
Revenue growth (last year)-27.24%
P/E ratioNM
Price/Sales--
Price/Book7.77

Competitors

 Today’s
change
Today’s
% change
GWPHGW Pharmaceuticals P...+0.23+0.19%
MYGNMyriad Genetics Inc-0.77-2.24%
LCILannett Company Inc0.000.00%
--COSMO Pharmaceutical...+1.20+0.75%
Data as of 4:01pm ET, 04/24/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$1.31
Annual revenue (last year)$25.2M
Annual profit (last year)-$93.8M
Net profit margin-371.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stuart W. Peltz
Chief Financial Officer
Shane William Charles Kovacs
Corporate headquarters
South Plainfield, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers